Incannex Healthcare, the Melbourne-based clinical-stage biopharmaceutical company developing therapies for the treatment of obstructive sleep apnea, rheumatoid arthritis and generalized anxiety ...

CAR T-cell therapy demand is rising, prompting institutions to expand access and reduce care barriers, exemplified by Vanderbilt-Ingram Cancer Center's outpatient center. Dr. Oluwole emphasizes ...

The Patient Advocate Foundation and the PAN Foundation have announced a strategic merger to create the nation’s most ...

Expanding clinical trial access locally reduces logistical and financial barriers, making participation feasible for underserved populations. Addressing myths about clinical trials helps patients ...

RPM may improve patient access to care, especially those with high-risk conditions, but not without a significant cost. Remote physiological monitoring (RPM), especially for patients with ...

Scientific breakthroughs are accelerating, but policy and payment systems have not kept pace. In this episode of Health Matters, John O’Brien, President and CEO of the National Pharmaceutical Council, ...

Patient engagement has matured from aspiration to necessity as precision medicine moves from laboratory concept to bedside. Cutting-edge therapies increasingly target narrowly defined genetic or ...

Angel Foundation in Minnesota is taking the upcoming World Cancer Day to discuss how they work to support cancer patients and their families. The foundation is designed to help provide relief for ...

Payers and providers are eager to elevate the patient journey, but for many patients, it still begins with friction. Extended wait times, complex intake processes, and unclear billing can derail the ...

Fewer patients are experiencing obstacles to accessing healthcare, according to a new survey, although persistent systemic issues limit improvements. How will this affect the revenue cycle? There is ...